thymopentin has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, R; He, H; Li, F; Tang, X; Yang, R | 1 |
| Cai, CF; Gao, RC; He, HB; Li, F; Tang, X; Xu, H; Yang, R | 1 |
2 other study(ies) available for thymopentin and Alloxan Diabetes
| Article | Year |
|---|---|
The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Drug Carriers; Drug Stability; Emulsions; Excipients; Gastrointestinal Tract; Hydrophobic and Hydrophilic Interactions; Insulin; Lipids; Male; Nanoparticles; Particle Size; Proteins; Rats; Rats, Sprague-Dawley; Thymopentin; Viscosity | 2011 |
Preparation of gel-core-solid lipid nanoparticle: a novel way to improve the encapsulation of protein and peptide.
Topics: Animals; Diabetes Mellitus, Experimental; Drug Delivery Systems; Drug Stability; Emulsions; Gels; Hypoglycemic Agents; Insulin; Lipids; Male; Mice; Nanoparticles; Particle Size; Protein Stability; Rats; Rats, Sprague-Dawley; Temperature; Thymopentin | 2010 |